Vident Investment Advisory, LLC Insulet Corp Transaction History

Vident Investment Advisory, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $498,992 - $746,936	-2,677 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $31,752 - $44,939	-163 Reduced 5.74%	2,677 $713,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $254,809 - $317,653	-998 Reduced 26.0%	2,840 $755,000
Q3 2021 Nov 12, 2021	SELL	$260.36 - $307.27 $259,578 - $306,348	-997 Reduced 20.62%	3,838 $1.09 Million
Q2 2021 Aug 13, 2021	SELL	$225.52 - $304.06 $287,989 - $388,284	-1,277 Reduced 20.89%	4,835 $1.33 Million
Q1 2021 May 14, 2021	SELL	$235.95 - $293.05 $7,786 - $9,670	-33 Reduced 0.54%	6,112 $1.6 Million
Q4 2020 Feb 08, 2021	SELL	$215.97 - $265.89 $14,469 - $17,814	-67 Reduced 1.08%	6,145 $1.57 Million
Q3 2020 Nov 12, 2020	SELL	$192.55 - $236.59 $5,198 - $6,387	-27 Reduced 0.43%	6,212 $1.47 Million
Q2 2020 Jul 17, 2020	BUY	$159.17 - $224.73 $621,081 - $876,896	3,902 Added 166.97%	6,239 $1.21 Million
Q1 2020 May 12, 2020	SELL	$130.01 - $216.44 $153,151 - $254,966	-1,178 Reduced 33.51%	2,337 $387,000
Q4 2019 Feb 11, 2020	BUY	$144.81 - $186.0 $509,007 - $653,790	3,515 New	3,515 $602,000

699

62.7M

640K

841K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.